Breathe BioMedical Inc. (BRTH)

Breathe BioMedical Statistics

Total Valuation

BRTH has a market cap or net worth of $57.36 million. The enterprise value is $57.91 million.

Market Cap	57.36M
Enterprise Value	57.91M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

BRTH has 11.47 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	11.47M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	466.59
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	19.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -6,075.51% and return on invested capital (ROIC) is -325.59%.

Return on Equity (ROE)	-6,075.51%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-325.59%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$293,783
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.04M
Pretax Income	-7.47M
Net Income	-7.64M
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	-$0.67

Balance Sheet

The company has $1.79 million in cash and $2.35 million in debt, giving a net cash position of -$553,689 or -$0.05 per share.

Cash & Cash Equivalents	1.79M
Total Debt	2.35M
Net Cash	-553,689
Net Cash Per Share	-$0.05
Equity (Book Value)	122,932
Book Value Per Share	0.01
Working Capital	n/a

Cash Flow

In the last 12 months, operating cash flow was -$4.37 million and capital expenditures -$573,544, giving a free cash flow of -$4.95 million.

Operating Cash Flow	-4.37M
Capital Expenditures	-573,544
Free Cash Flow	-4.95M
FCF Per Share	-$0.43

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BRTH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-13.32%
FCF Yield	-8.62%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1